Evidence map›Paper›PMID 33753897›Full record

ArticlePediatric research2022

Characterizing mucociliary clearance in young children with cystic fibrosis.

Beth L Laube, Kathryn A Carson, Christopher M Evans, Melis A Aksit, Joseph M Collaco, Vanessa L Richardson, Gail Sharpless, Pamela L Zeitlin, Garry R Cutting, Peter J Mogayzel

Abstract read
In one paragraph

Article in Pediatric research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Beth L LaubeDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. blaube@jhmi.edu.
Kathryn A CarsonDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Christopher M EvansDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Melis A AksitMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Joseph M CollacoDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Vanessa L RichardsonDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Gail SharplessDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pamela L ZeitlinDepartment of Pediatrics, National Jewish Health, Denver, CO, USA.
Garry R CuttingMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Peter J MogayzelDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Role of Mucin in Lung Homeostasis and PathophysiologyR01HL080396 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Christopher M Evans · 2009 to 2026
$8.6M
Lung Macrophage Programming in Acute Lung InjuryR35HL140039 · NHLBI · NATIONAL JEWISH HEALTH · PI JANSSEN, WILLIAM · 2018 to 2024
$6.4M
Mechanisms of lung macrophage programming by MUC5B during health and diseaseR01HL130938 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI EVANS, CHRISTOPHER M · 2016 to 2025
$5.2M
Gene-Environment Interactions in Cystic Fibrosis Lung DiseaseR01HL128475 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COLLACO, JOSEPH MICHAEL · 2016 to 2019
$1.1M
Defining the Pulmonary Attributes of Pre-symptomatic Lung Disease in Cystic FibrosisR01HL129925 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI LAUBE, BETH L, ZEITLIN, PAMELA L. · 2015 to 2017
$951k
Fungal Exposure and the Respiratory Tract MicrobiomeR21ES023384 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI EVANS, CHRISTOPHER M · 2014 to 2016
$931k
NCATS NIH HHS UL1 TR001079NHLBI NIH HHS R01 HL080396NHLBI NIH HHS R01 HL128475NHLBI NIH HHS R01 HL129925NHLBI NIH HHS R01 HL130938NHLBI NIH HHS R35 HL140039NIEHS NIH HHS R21 ES023384
6 · The paper itself

Abstract

backgroundThis research characterized mucociliary clearance (MCC) in young children with cystic fibrosis (CF).

methodsFourteen children (5-7 years old) with CF underwent: two baseline MCC measurements (Visits 1 and 2); one MCC measurement approximately 1 year later (Visit 3); and measurements of lung clearance index (LCI), a measure of ventilation inhomogeneity.

resultsMedian (range) percent MCC through 60 min (MCC60) was similar on Visits 1 and 2 with 11.0 (0.9-33.7) and 12.8 (2.7-26.8), respectively (p = 0.95), and reproducible (Spearman Rho = 0.69; p = 0.007). Mucociliary clearance did not change significantly over 1 year with median percent MCC60 on Visit 3 [12.8 (3.7-17.6)] similar to Visit 2 (p = 0.58). Lower percent MCC60 on Visit 3 was significantly associated with higher LCI scores on Visit 3 (N = 14; Spearman Rho = -0.56; p = 0.04).

conclusionsTests of MCC were reproducible and reliable over a 2-week period and stable over a 1-year period in 5-7-year-old children with CF. Lower MCC values were associated with increased ventilation inhomogeneity. These results suggest that measurements of MCC could be used in short-term clinical trials of interventions designed to modulate MCC and as a new, non-invasive test to evaluate early lung pathology in children with CF. IMPACT: This is the first study to characterize mucociliary clearance (MCC) in children with cystic fibrosis (CF) who were 5-7 years old. Measurements of mucociliary clearance were reproducible and reliable over a 2-week period and stable over a 1-year period. Variability in MCC between children was associated with differences in ventilation homogeneity, such that children with lower MCC values had increased ventilation inhomogeneity. These results suggest that measurements of MCC could be used in short-term clinical trials of interventions designed to modulate MCC and as a new, non-invasive test to evaluate early lung pathology in children with CF.

Indexed as

Cystic FibrosisMucociliary ClearanceChildChild, PreschoolHumansLungRespirationRespiratory Function Tests

Identifiers

PMID33753897
PMCPMC8455702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.